Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430371 · ClinicalTrials.gov registry record · NA
Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support (VR-CARES)
A NA study of Peer Support and Dementia Caregiver, sponsored by Rendever.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT07430371: Recruiting NA study of Peer Support and Dementia Caregiver, sponsored by Rendever.
NCT07430371 is a NA study of Peer Support and Dementia Caregiver that is actively recruiting participants, run by Rendever. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430371, a NA study of Peer Support and Dementia Caregiver, is actively recruiting participants, sponsored by Rendever.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
The VR-CARES project is an innovative, collaborative effort that invites dementia care professionals into the design process of a virtual reality platform seeking to mitigate their work-related burden and social isolation by cultivating a virtual community of support. The co-created, caregiver-specific VR platform will serve as a safe, communal space where caregivers can remotely connect with their peers, share fun experiences together, access support, learn self-care and build resilience within a supportive virtual network to enhance their social and mental health and job satisfaction. Central to VR-CARES in the principle of user-led innovation, ensuring that the technology not only serves but is informed and successfully adopted by the very individuals it intends to benefit, an important standard for empathetic and inclusive technology in healthcare.
Primary Outcome
A 10-item questionnaire measuring subjective usability of the VR technology platforms. To gain more nuanced meaning from the data, items are rated using a numerical response scale with ratio properties and finite anchors, the Global Hedonic Intensity Scale (GHIS), in place of a 5-point categorical scale. The GHIS is a bipolar 100-point sliding scale with -100 representing the most unpleasant personal experience, 0 neutral, and +100 representing the most pleasurable personal experience (Bartoshuk
Conditions Studied
Interventions
- BEHAVIORAL Rendever VR Social Engagement Platform
- BEHAVIORAL VR-CARES Platform
Study Locations (5)
Michigan
- Right at Home - Brighton
- Right at Home - East Lansing
- Right at Home - Novi
- Right at Home - Owosso
Massachusetts
- Rendever, Inc. - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07430371 shows while recruiting
NCT07430371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Peer Support appearing as the primary indexed condition, and to 2 interventions - of which Rendever VR Social Engagement Platform is the first listed.
NCT07430371 lists 5 locations in 2 states (Michigan, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT07430371 about?
NCT07430371 is a clinical study titled "Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support (VR-CARES)". The VR-CARES project is an innovative, collaborative effort that invites dementia care professionals into the design process of a virtual reality platform seeking to mitigate their work-related burden and social isolation by cultivating a virtual community of support. The co-created, caregiver-speci...
What is the current status of trial NCT07430371?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02. Estimated completion is 2026-08.
What conditions does trial NCT07430371 study?
This clinical trial studies the following conditions: Peer Support, Dementia Caregiver, Caregiver Social Support, Direct Care Workers, In-Home Care.
What interventions are being tested in trial NCT07430371?
The interventions under investigation include: Rendever VR Social Engagement Platform (BEHAVIORAL), VR-CARES Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT07430371?
This trial is sponsored by Rendever, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07430371 being conducted?
This trial has 5 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peer Support
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07430371's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia